Unknown

Dataset Information

0

Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis.


ABSTRACT: Clostridium butyricum MIYAIRI 588 (CBM 588) is a probiotic bacterium that has previously been used to prevent antibiotic-associated diarrhea. However, the underlying mechanism by which CBM 588 protects the gut epithelial barrier remains unclear. Here, we show that CBM 588 increased the abundance of Bifidobacterium, Lactobacillus, and Lactococcus species in the gut microbiome and also enhanced the intestinal barrier function of mice with antibiotic-induced dysbiosis. Additionally, CBM 588 significantly promoted the expansion of IL-17A-producing ??T cells and IL-17A-producing CD4 cells in the colonic lamina propria (cLP), which was closely associated with changes in the intestinal microbial composition. Additionally, CBM 588 plays an important role in controlling antibiotic-induced gut inflammation through upregulation of anti-inflammatory lipid metabolites such as palmitoleic acid, 15d-prostaglandin J2, and protectin D1. This study reveals a previously unrecognized mechanism of CBM 588 and provides new insights into gut epithelial barrier protection with probiotics under conditions of antibiotic-induced dysbiosis.

SUBMITTER: Hagihara M 

PROVIDER: S-EPMC6970176 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7661741 | BioStudies
2020-10-14 | MTBLS2087 | MetaboLights
2013-01-01 | S-EPMC3656030 | BioStudies
| GSE123163 | GEO
1000-01-01 | S-EPMC5537250 | BioStudies
2016-01-01 | S-EPMC5014122 | BioStudies
2015-01-01 | S-EPMC4320100 | BioStudies
2019-01-01 | S-EPMC6613141 | BioStudies
2016-06-01 | E-MTAB-3722 | ArrayExpress
2015-01-01 | S-EPMC5555213 | BioStudies